These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development of a humanized C1q A chain knock-in mouse: assessment of antibody independent beta-amyloid induced complement activation. Li M; Ager RR; Fraser DA; Tjokro NO; Tenner AJ Mol Immunol; 2008 Jun; 45(11):3244-52. PubMed ID: 18400300 [TBL] [Abstract][Full Text] [Related]
3. Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: implications for Alzheimer's disease pathogenesis. Velazquez P; Cribbs DH; Poulos TL; Tenner AJ Nat Med; 1997 Jan; 3(1):77-9. PubMed ID: 8986745 [TBL] [Abstract][Full Text] [Related]
4. Inhibiting the formation of classical C3-convertase on the Alzheimer's beta-amyloid peptide. Emmerling MR; Spiegel K; Watson MD Immunopharmacology; 1997 Dec; 38(1-2):101-9. PubMed ID: 9476121 [TBL] [Abstract][Full Text] [Related]
5. Expression of complement system components during aging and amyloid deposition in APP transgenic mice. Reichwald J; Danner S; Wiederhold KH; Staufenbiel M J Neuroinflammation; 2009 Nov; 6():35. PubMed ID: 19917141 [TBL] [Abstract][Full Text] [Related]
6. beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain. Jiang H; Burdick D; Glabe CG; Cotman CW; Tenner AJ J Immunol; 1994 May; 152(10):5050-9. PubMed ID: 8176223 [TBL] [Abstract][Full Text] [Related]
9. Charge-based binding of complement component C1q to the Alzheimer amyloid beta-peptide. Webster S; Bonnell B; Rogers J Am J Pathol; 1997 May; 150(5):1531-6. PubMed ID: 9137079 [TBL] [Abstract][Full Text] [Related]
10. Induced expression of neuronal membrane attack complex and cell death by Alzheimer's beta-amyloid peptide. Shen Y; Sullivan T; Lee CM; Meri S; Shiosaki K; Lin CW Brain Res; 1998 Jun; 796(1-2):187-97. PubMed ID: 9689469 [TBL] [Abstract][Full Text] [Related]
11. Activation of complement and contact system in Alzheimer's disease. Bergamaschini L; Donarini C; Gobbo G; Parnetti L; Gallai V Mech Ageing Dev; 2001 Nov; 122(16):1971-83. PubMed ID: 11589915 [TBL] [Abstract][Full Text] [Related]
12. Beta-amyloid fibrils activate the C1 complex of complement under physiological conditions: evidence for a binding site for A beta on the C1q globular regions. Tacnet-Delorme P; Chevallier S; Arlaud GJ J Immunol; 2001 Dec; 167(11):6374-81. PubMed ID: 11714802 [TBL] [Abstract][Full Text] [Related]
13. Modular organization of the carboxyl-terminal, globular head region of human C1q A, B, and C chains. Kishore U; Gupta SK; Perdikoulis MV; Kojouharova MS; Urban BC; Reid KB J Immunol; 2003 Jul; 171(2):812-20. PubMed ID: 12847249 [TBL] [Abstract][Full Text] [Related]
14. Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner. Bergamaschini L; Canziani S; Bottasso B; Cugno M; Braidotti P; Agostoni A Clin Exp Immunol; 1999 Mar; 115(3):526-33. PubMed ID: 10193429 [TBL] [Abstract][Full Text] [Related]
15. Induction of complement proteins in a mouse model for cerebral microvascular A beta deposition. Fan R; DeFilippis K; Van Nostrand WE J Neuroinflammation; 2007 Sep; 4():22. PubMed ID: 17877807 [TBL] [Abstract][Full Text] [Related]
16. The role of complement in Alzheimer's disease pathology. Emmerling MR; Watson MD; Raby CA; Spiegel K Biochim Biophys Acta; 2000 Jul; 1502(1):158-71. PubMed ID: 10899441 [TBL] [Abstract][Full Text] [Related]
17. Complement component C1q modulates the phagocytosis of Abeta by microglia. Webster SD; Yang AJ; Margol L; Garzon-Rodriguez W; Glabe CG; Tenner AJ Exp Neurol; 2000 Jan; 161(1):127-38. PubMed ID: 10683279 [TBL] [Abstract][Full Text] [Related]
18. Complement C3 Is Activated in Human AD Brain and Is Required for Neurodegeneration in Mouse Models of Amyloidosis and Tauopathy. Wu T; Dejanovic B; Gandham VD; Gogineni A; Edmonds R; Schauer S; Srinivasan K; Huntley MA; Wang Y; Wang TM; Hedehus M; Barck KH; Stark M; Ngu H; Foreman O; Meilandt WJ; Elstrott J; Chang MC; Hansen DV; Carano RAD; Sheng M; Hanson JE Cell Rep; 2019 Aug; 28(8):2111-2123.e6. PubMed ID: 31433986 [TBL] [Abstract][Full Text] [Related]
19. C1q-induced LRP1B and GPR6 proteins expressed early in Alzheimer disease mouse models, are essential for the C1q-mediated protection against amyloid-β neurotoxicity. Benoit ME; Hernandez MX; Dinh ML; Benavente F; Vasquez O; Tenner AJ J Biol Chem; 2013 Jan; 288(1):654-65. PubMed ID: 23150673 [TBL] [Abstract][Full Text] [Related]
20. JNK activation is associated with intracellular beta-amyloid accumulation. Shoji M; Iwakami N; Takeuchi S; Waragai M; Suzuki M; Kanazawa I; Lippa CF; Ono S; Okazawa H Brain Res Mol Brain Res; 2000 Dec; 85(1-2):221-33. PubMed ID: 11146125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]